Ping An Good Doctor Acquires Jiangsu Zhongyikang Pharmaceutical Co., Ltd. to Enter B2B Medical E-commerce

The 21st Century Business Herald reporter learned from the relevant person of Ping An Good Doctor that Ping An Good Doctor has recently obtained the "Pharmaceutical Business License" (wholesale), and has the ability to carry out B2B business and pharmaceutical wholesale business online and offline, or Enter the B2B medical e-commerce field, accelerate the layout of the industry chain, and integrate the capabilities of pharmaceutical wholesale, pharmaceutical supply chain, health mall, cooperative pharmacy, Internet hospital, cooperative hospital, online consultation + family doctor and consumer medical care.

Earlier this year, Ping An Doctor had acquired Jiangsu Zhongyikang Pharmaceutical Co., Ltd. (hereinafter referred to as “Zhongyikang”), and obtained the “Pharmaceutical Business License” (wholesale), according to the “State Council issued last year”. Regarding the third batch of decisions to cancel the implementation of administrative licensing items in designated central areas, enterprises that have obtained the "Pharmaceutical Business License" (wholesale) may be deemed to have obtained the "Internet Drug Trading Service Qualification Certificate" (B certificate).

According to public information, Ping An has previously obtained the A and C certificates of the Internet Drug Trading Service Qualification Certificate in 2014 and 2016 respectively, and has the third-party medical Internet platform service capability and pharmaceutical retail capacity. After obtaining the B2B business qualification, the drug can be directly purchased from the pharmaceutical production enterprise, thereby forming a B2B2C model and reducing the procurement cost of the health mall business.

At the same time, Ping An’s doctor will further contribute to the pharmaceutical market. The Ministry of Commerce released the "Statistical Analysis Report on the Operation of Drug Circulation Industry in 2017", which showed that the circulation of pharmaceuticals in China reached 201.6 billion yuan in 2017, and the unparalleled factor was 8.4% higher than last year. As of the end of 2017, there were 13,146 pharmaceutical wholesale enterprises nationwide, an increase of 171 over the previous year. In terms of market share, 4 national leading enterprises such as Sinopharm and China Resources accounted for 37.6%, and 30 regional leading enterprises accounted for 24.5%. It can be seen that the number of pharmaceutical wholesale enterprises increased in 2017, sales growth slowed down, and the concentration decreased slightly.

It can be seen that although China's pharmaceutical market is huge, its concentration is not high, the pharmaceutical distribution network is relatively scattered, and geographical differences are obvious. Among the more than 13,000 pharmaceutical wholesale enterprises in the country, most of them are regional enterprises, covering less provinces and low market share.

In order to improve the situation of “multiple, scattered, chaotic and low” in the Chinese pharmaceutical circulation market, in early 2017, the General Office of the State Council issued the “Several Opinions on Further Reforming and Perfecting the Policy of Drug Production and Use” to support the cross-regional distribution of drug circulation enterprises and accelerate the formation. Large backbone enterprises are the mainstay, and small and medium-sized enterprises are complementary to the urban and rural drug circulation network.

Wang Tao, chairman and CEO of Ping An Good Doctor, previously revealed that Ping An has already cooperated with more than 10,000 offline pharmacies and launched the “one-hour delivery” service in dozens of cities across the country. This figure has increased significantly from the 7,500 companies disclosed in the previous prospectus.

In the eyes of industry professionals, medical e-commerce can only develop rapidly if medical e-commerce is included in the Internet medical system. Prescription excretion will drive the reconstruction of medical-related information flow, service flow, capital flow, and logistics. However, the current prescription circulation platform has government-led and third-party construction, and it has not been fully opened. In the future, the pharmaceutical e-commerce O2O model will become the main e-commerce model.

Serial Laser Distance Sensor

With low-power, miniature size, the serial communication department range sensor with mm accuracy can measure up to 20m, 40m, 60m, 100m, 150m, 200m.
If you want to connect our laser range sensor boards together with your computer, you can directly choose the model with one USB connector.
In your project, you can use our distance sensor panel to measure a distance.
JRT Serial Laser Distance Sensor

Serial Laser Distance Sensor,Serial Communication Laser Distance Sensor,Laser Range Sensor Boards,Distance Sensor Panel

Chengdu JRT Meter Technology Co., Ltd , https://www.rangesensors.com